Benjamin Cottam

1.1k total citations
14 papers, 949 citations indexed

About

Benjamin Cottam is a scholar working on Oncology, Immunology and Psychiatry and Mental health. According to data from OpenAlex, Benjamin Cottam has authored 14 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Immunology and 2 papers in Psychiatry and Mental health. Recurrent topics in Benjamin Cottam's work include Cancer Immunotherapy and Biomarkers (9 papers), Immune cells in cancer (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Benjamin Cottam is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Immune cells in cancer (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Benjamin Cottam collaborates with scholars based in United States, United Kingdom and Belgium. Benjamin Cottam's co-authors include Michael J. Gough, Marka R. Crittenden, Pippa Newell, David J. Friedman, Jason R. Baird, Shelly Bambina, Talicia Savage, Keith S. Bahjat, Kristina H. Young and Thomas W. Dubensky and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Benjamin Cottam

14 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Cottam United States 11 672 628 153 124 83 14 949
Brian J. Francica United States 9 692 1.0× 488 0.8× 133 0.9× 272 2.2× 66 0.8× 24 944
Anna Kwilas United States 16 587 0.9× 457 0.7× 240 1.6× 246 2.0× 49 0.6× 24 969
Felix Klug Germany 8 650 1.0× 616 1.0× 192 1.3× 181 1.5× 148 1.8× 8 1.0k
Gulidanna Shayan United States 10 771 1.1× 808 1.3× 218 1.4× 120 1.0× 25 0.3× 20 1.2k
Welby Montalvo-Ortiz United States 4 993 1.5× 993 1.6× 159 1.0× 96 0.8× 125 1.5× 5 1.3k
Ornella Pagliano United States 9 1.2k 1.8× 1.3k 2.0× 206 1.3× 90 0.7× 35 0.4× 17 1.6k
Todd Bartkowiak United States 11 513 0.8× 637 1.0× 234 1.5× 96 0.8× 61 0.7× 21 963
Myrna Rauckhorst United States 12 707 1.1× 550 0.9× 186 1.2× 270 2.2× 87 1.0× 25 971
Anne Marie Yang United States 3 738 1.1× 611 1.0× 81 0.5× 191 1.5× 102 1.2× 5 957
Akihiro Hosoi Japan 16 568 0.8× 592 0.9× 236 1.5× 158 1.3× 71 0.9× 30 928

Countries citing papers authored by Benjamin Cottam

Since Specialization
Citations

This map shows the geographic impact of Benjamin Cottam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Cottam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Cottam more than expected).

Fields of papers citing papers by Benjamin Cottam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Cottam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Cottam. The network helps show where Benjamin Cottam may publish in the future.

Co-authorship network of co-authors of Benjamin Cottam

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Cottam. A scholar is included among the top collaborators of Benjamin Cottam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Cottam. Benjamin Cottam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gunderson, Andrew J., Tomoko Yamazaki, Kayla McCarty, et al.. (2019). Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma. PLoS ONE. 14(2). e0211117–e0211117. 58 indexed citations
2.
Tang, Ephraim, Philippa Newell, Ronald Wolf, et al.. (2018). Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer. JAMA Surgery. 153(11). 1055–1055. 12 indexed citations
3.
Young, Kristina H., Jason R. Baird, Talicia Savage, et al.. (2016). Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy. PLoS ONE. 11(6). e0157164–e0157164. 257 indexed citations
4.
Crocenzi, Todd S., Benjamin Cottam, Pippa Newell, et al.. (2016). A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma. Journal for ImmunoTherapy of Cancer. 4(1). 45–45. 80 indexed citations
5.
Crittenden, Marka R., Jason R. Baird, David J. Friedman, et al.. (2016). Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy. Oncotarget. 7(48). 78653–78666. 75 indexed citations
6.
Young, Kristina H., Kayla McCarty, David J. Friedman, et al.. (2016). Preclinical combination of radiation and fibroblast activation protein inhibition in pancreatic cancer.. Journal of Clinical Oncology. 34(15_suppl). e23117–e23117. 2 indexed citations
7.
Friedman, David J., Jason R. Baird, Kristina H. Young, et al.. (2016). Programmed cell death‐1 blockade enhances response to stereotactic radiation in an orthotopic murine model of hepatocellular carcinoma. Hepatology Research. 47(7). 702–714. 52 indexed citations
8.
Baird, Jason R., David J. Friedman, Benjamin Cottam, et al.. (2015). Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors. Cancer Research. 76(1). 50–61. 201 indexed citations
9.
Young, Kristina H., Pippa Newell, Benjamin Cottam, et al.. (2014). TGFβ Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models. Cancer Immunology Research. 2(10). 1011–1022. 47 indexed citations
10.
Crittenden, Marka R., Talicia Savage, Benjamin Cottam, et al.. (2014). Expression of Arginase I in Myeloid Cells Limits Control of Residual Disease after Radiation Therapy of Tumors in Mice. Radiation Research. 182(2). 182–190. 35 indexed citations
11.
Baird, Jason R., Thomas W. Dubensky, David B. Kanne, et al.. (2014). Intratumoral injection of STING ligand promotes abscopal effect. Journal for ImmunoTherapy of Cancer. 2(S3). 1 indexed citations
12.
Friedman, David J., Kristina H. Young, Jason R. Baird, et al.. (2014). Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy. Journal for ImmunoTherapy of Cancer. 2(S3). 1 indexed citations
13.
Crittenden, Marka R., Talicia Savage, Benjamin Cottam, et al.. (2013). The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor. PLoS ONE. 8(7). e69527–e69527. 39 indexed citations
14.
Crittenden, Marka R., Benjamin Cottam, Talicia Savage, et al.. (2012). Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy. PLoS ONE. 7(6). e39295–e39295. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026